ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[CD274, IL23A, PRG2, LILRB1, PDCD1LG2, FCGR2B, DLL1, JAK3]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, ARRB1, ARRB2, TNF, CLU, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, GREM1, SFRP4, IL1B, DOCK2, NLGN1, CD151, LRP1, NEDD4L, DLL1, C2, RAB21, C3, NTF3, PLCG2, STAP1, CCL2, NCKAP1L, CCL19, CD14, SNCA, CCL21, EGF, AZU1, SELE, TF, DAB2, SYNJ1, F2RL1, PTX3, FCGR2B]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCH, PRKCD, CCL2, DLL1]
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;663.4179201744114;5.8650506222523235;0.02220400075087234;0.6961795867550195;[GAB1, PIK3CD, PIK3R3, PIK3C2A, FGF5, PIKFYVE, SYNJ1, PIK3C3]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA1, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, PIK3C3, HBEGF, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CEP120, CXCR4, CDH1, PRDM16, EPHB1, TGFB2, ANXA1, NUP133, BCL11B, BCL11A, CIT, CDK6, FABP7]
GO:0048633;positive regulation of skeletal muscle tissue growth;9.0;1.0;0.896240625180289;9.628524252492122;367.14841175535776;8.390779266560578;0.012288126929333416;0.8253454670833372;[RPS6KB1, DLL1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0003334;keratinocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.35043118565193;7.57984905034425;0.0011496780184027697;0.6778748447945537;[BCL11B, PALLD, SFN]
GO:0072070;loop of Henle development;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;58.05347923817328;8.390779266560578;0.001942997705362361;0.8041048419030481;[JAG1, DLL1]
GO:0072583;clathrin-dependent endocytosis;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;30.046907922432062;6.558197802812269;0.0010056429677022863;0.6863059058804069;[ITGA4, DLL1, AP2M1]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, NEDD4L, PAK1, SFN, TGFB2, SYT2, FN1, CXCL12, BCL2]
GO:0071376;cellular response to corticotropin-releasing hormone stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;8.16763571524637;0.015486127626965131;0.7926932703116032;[NR4A2, NR4A1, NR4A3]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[CCNA2, PID1, NR4A3]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[IHH, DLL1, MEF2C, STIL, ENG]
GO:0031077;post-embryonic camera-type eye development;7.0;1.0;0.8509193652572005;9.628524252492122;36.784493016758105;8.390779266560578;0.0012311438773764656;0.7800242071602487;[BCL11B, FZD5, KLF4]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, CCR3, IL10, PPP1R16B, GHSR, MED1, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, HTRA1, TGFA, TWIST1, NOD2, IQGAP3, NRAS, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, PDGFA, PIK3C2A, PDGFRL, NR4A3, PDGFD, PDGFC]
GO:0009444;pyruvate oxidation;8.0;1.0;0.875;9.628524252492122;62.86773511860113;9.777073627680469;0.002104126517131282;0.875;[NR4A3]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0010828;positive regulation of glucose transmembrane transport;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;65.58818238534796;5.845247994956144;0.0021951774389057117;0.6498456195510879;[PIK3R3, PRKCZ, C3, PAK1, AKT1, MEF2A, NR1H4, SORBS1, MAPK14, GH1, NR4A3]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[TGFB1, IL18, DLL1, TNF, CXCL10]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0035265;organ growth;3.0;0.7671156992804218;0.5816781622303554;8.753055515138222;22.582921643529833;6.444869117505266;7.558300640989654E-4;0.5277112189764278;[PDGFRB, PSAP, BCL2, DLL1]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PIK3C2A, AKT1, GAB1, PIK3R3, PRKCZ, FOXO1, CAV2, SORBS1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, MIF, RRAGD, AURKAIP1, GATA3, RAD21, TP53BP2, SFN, BARD1, CDT1, PLK2, PLK1, LIF, CDC6, NR2F2, ZWINT, STAG2, EZH2, TOP2A, CDKN1A, BTG2, PTPRK, BRCA1, BRCA2, BMI1, TIMP2, IL10, DUSP1, STRADB, GAS1, PCNA, PTGS2, GPNMB, APBB1, CDKN2C, LILRB1, CENPF, FAP, TRIP13, SIPA1, MAD2L1, ZWILCH, GMNN, BUB1B, TNF, KNTC1, MEN1, MSH6, ADCYAP1, MSH2, MAD1L1, BLM, CUL5, CCNB1, NACC2, NAE1, GAS2L1, MAP2K6, FANCI, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, CDK6, BCL6, CNOT3, JMY, CDK1, BCL2, BCL2L1, TNFAIP3, HHEX, TOPBP1, MYOCD, H2AFX, SMC1A, TFDP1, IFNG, DTL, PPP1R15A, CEBPA, THBS1, AURKB, CDC45, RBBP8, E2F1, CCL2, BUB1, E2F7, RRM2, DONSON, MAPK14, KLF4, PML, WEE1, RAD51, EVI2B]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNC, PHB2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, CDCA5, TGFA, RACGAP1, RAD21, SFN, CDT1, PLK2, CDC6, CD28, CDKN1A, FEN1, BTG2, BRCA1, BRCA2, IL10, EDN1, ANXA1, DUSP3, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, PDGFRB, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK1, NUP62, CCNA2, PSRC1, TFDP1, DTL, SMARCD3, VPS4B, AURKB, CDC45, E2F1, E2F7, SH2B1, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:0038097;positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;425.1978941221189;9.777073627680469;0.014230990863006563;0.9152410118609203;[NR4A3]
GO:0045664;regulation of neuron differentiation;7.0;0.5064924996362321;0.6041656150753165;7.722354432086322;62.256296269576055;3.3619766685088743;0.0020836622091136505;0.5228510084326481;[CYFIP1, CPNE5, GFI1, CDC20, EDNRB, LGALS1, DPYSL2, AKT1, HOXA2, EPHB2, MED1, MEF2C, PAQR3, SFRP2, MAP1B, EPHA3, SDC2, NEDD4L, GATA3, THY1, LYN, FZD1, JAG1, BCL11B, PLK2, FN1, PTK2, ID1, EZH2, ITM2C, ROBO2, NRP1, CTSZ, ARHGAP4, TIMP2, CD38, RGMA, NME1, IL1B, RARA, PAK1, NTF3, SPP1, APBB1, XK, NEDD4, FKBP1B, CAMK1, SCARB2, SEMA5B, PLXND1, FMR1, ARHGDIA, TNR, EOMES, SEMA6A, ADCYAP1, S100A9, SOCS2, ECT2, SYT2, BMP2, CXCL12, LIN28A, BCL6, FES, BCL2, PLXNB2, TCF4, LRRK2, YWHAH, DCC, DNM2, ASPM, SHANK3, NLGN1, HDAC2, LRP1, RNF6, DLL1, RAB21, CNR1, FYN, S1PR5, LINGO1, SEMA4A, PRRX1, SEMA4B, IRX3, KLF4, MEIS1, PMP22]
GO:0046632;alpha-beta T cell differentiation;7.0;0.7140352122741334;0.7079369713942671;9.04870575723918;90.58502354652471;6.166155715036245;0.0030317992168737967;0.6662568552797195;[ITK, BLM, LEF1, TCF7, RORA, GATA3, RELB, FUT7, NKX2-3, EOMES, SEMA4A, ANXA1, BCL11B, RSAD2, BMX, BCL3, GPR18, IL18R1]
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;244.58802208207217;7.212124270218933;0.008186140984158152;0.7650689957573628;[DOCK5, PAK1, DOCK4, NR4A3, IGFBP5]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, RORA, BRCA1, NR3C2, HNF4A, YWHAH, MED1, CCNE1, RARA, PADI2, YAP1, NR1I2, LEF1, RXRA, VDR, NR1H2, NR1H4, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, NEDD4, RAN]
GO:0021773;striatal medium spiny neuron differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;28.520945732161007;8.67846133901236;9.545703864707246E-4;0.7947362817240173;[BCL11B, INHBA, SHANK3]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, STAT1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MAP3K8, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0051549;positive regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;297.9389118084288;7.697632086000634;0.009971747250615804;0.7898978880348613;[EPB41L4B, ADAM9, MMP9, HBEGF]
GO:2000253;positive regulation of feeding behavior;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;36.79969893521793;7.474488534686424;0.0012316528057828779;0.6724867031240476;[GHSR, NR4A3]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[PTPRR, CUL5, EGF, GAB1, MATK, EREG, BTC, HBEGF]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, PDE4D, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, NFKBID, LAT, HLA-DRB1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0051545;negative regulation of elastin biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;967.9208223894049;9.777073627680469;0.032395438853188026;0.896240625180289;[HBEGF]
GO:0030522;intracellular receptor signaling pathway;5.0;0.6547035408479693;0.617592782284905;7.98629651723503;23.17027026302992;4.6122876537569555;7.75488093814194E-4;0.5261136169673617;[RORA, SLA2, MED1, ACTN4, CCNE1, PADI2, MAP2K6, VDR, DEFA1, NR2F2, NR4A2, NFKBIA, NR4A1, NR4A3, TGFB1I1, FHL2, HNF4G, TNFAIP3, BRCA1, IFIH1, HNF4A, YWHAH, DDX58, RIPK2, RARA, IRF7, YAP1, NR1I2, NOD2, RXRA, NR1H2, NR1H4, PML, NEDD4, RAN]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[IL10, PPP1R16B, GHSR, NRP1, ANXA1, PLK2, PTGS2, KLF4, PIK3C2A, DLL1, AGTR1, HMOX1]
GO:0038089;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.537552474286395;192.4558414516795;7.8311634786251565;0.006441323814375438;0.7967266896635242;[GAB1]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[POSTN, EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:0003323;type B pancreatic cell development;7.0;1.0;0.8509193652572005;9.628524252492122;37.346163459204256;7.379178354882098;0.001249942481614558;0.728290889492758;[CDK6, DLL1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[ACHE, TAGLN, LAMA2, TWIST1, AEBP1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0035767;endothelial cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;58.99646552848538;7.474488534686424;0.0019745586078665435;0.7572456912631272;[NR4A1, NRP1, EGR3, CXCL13]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, NRAS, AKT1, HMOX1, PLCG1, CCR3, IL10, PPP1R16B, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, VCAM1, AKT1, GAS1, MAPK14]
GO:0045608;negative regulation of inner ear auditory receptor cell differentiation;11.0;0.9326813400603323;0.8987696223598284;9.60185600540996;1107.5091840940604;8.67846133901236;0.03706733569807334;0.8762458687964789;[DLL1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, PIK3C2A, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[GREM1, NR4A1, NRP1, EGR3]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[STEAP4, FFAR2, MED1, GPX1, SIRT1, PLCB1, CEBPA, CEBPB, RETN, ADRB2, PTGS2, FOXO1, PRDM16, EGR2, LAMB3, NOC3L, KLF4, NR4A2, NR4A1, ALDH6A1, LRG1, NR4A3]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[LAT2, NR4A3, KIT, PIK3CD, RASGRP1, LAT]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, CCNC, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, RXRA, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:1903208;negative regulation of hydrogen peroxide-induced neuron death;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;1053.9315577462648;8.16763571524637;0.035274140760945843;0.8329342821725234;[IL10, NR4A3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0098773;skin epidermis development;5.0;0.8933024483968273;0.736892236059334;9.474373572664863;33.122816977724916;9.083926447120524;0.0011085908756445111;0.7547934328124444;[DLL1]
GO:0002315;marginal zone B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;7.57984905034425;0.005013908926038414;0.7838744581139225;[BCL3, DLL1, CDH17]
GO:0010613;positive regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.57844489853944;6.444869117505266;0.003198924535738274;0.7045909063862833;[MEF2A, CAMK2D, EDN1, TRPC3, PTK2, NR4A3, PDE5A]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0090668;endothelial cell chemotaxis to vascular endothelial growth factor;7.0;1.0;0.8509193652572005;9.628524252492122;32.925985058564954;9.777073627680469;0.0011020030884474538;0.8509193652572005;[GAB1]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[SERPINE1, PLEK, THBS1, MYLK, THBD, PDPN, CD36, ANXA1, PRKCE, F2R, F3, SELP, HPSE, TLR4, S100A9, HBEGF]
GO:0021902;commitment of neuronal cell to specific neuron type in forebrain;6.0;1.0;0.8231203125901445;9.628524252492122;23.23527948316835;7.8311634786251565;7.776638939077275E-4;0.7236063770733796;[BCL11B, SATB2]
GO:0003382;epithelial cell morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;47.452274261266446;6.409777797693995;0.0015881849152503491;0.6509166472493662;[ST14, BCL11B, COL23A1, IHH, SPINT2, GRHL2, CLDN3, POF1B, PALLD, ID1]
GO:0045333;cellular respiration;5.0;0.6799073451904818;0.6301946844561612;8.242229891372231;30.85741402911629;5.572381008289503;0.0010327698776848686;0.5752128357670632;[UQCRB, UQCR10, COX5B, COX6A1, COX5A, COX7C, UQCRH, COX8A, ADSL, NDUFS8, NR4A3, NDUFS7, NDUFS4, NDUFS3, UQCRC1, UQCRC2]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, IL18, PYCARD, IL23A, CD24, IL12RB1, IL6R, ICOSLG]
GO:1900746;regulation of vascular endothelial growth factor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;69.03899383076448;7.212124270218933;0.0023106729924551295;0.6919486831672181;[DLL1, DCN]
GO:1900625;positive regulation of monocyte aggregation;7.0;1.0;0.8509193652572005;9.628524252492122;70.45855976016728;8.67846133901236;0.0023581845865858486;0.7947362817240173;[NR4A3]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[LEF1, AXIN2, DLL1]
GO:0072014;proximal tubule development;8.0;0.8653626801206646;0.8076813400603323;9.36615998802463;58.05347923817328;8.390779266560578;0.001942997705362361;0.8041048419030481;[DLL1]
GO:0001757;somite specification;4.0;1.0;0.75;9.628524252492122;23.491373237041078;8.16763571524637;7.862351213804327E-4;0.6676932703116032;[DLL1]
GO:2000726;negative regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;669.6541776470041;7.292166977892469;0.022412722676212672;0.769162383550154;[PAK1, BMP2, DLL1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[CDK6, PLP1, TSPAN2, DLL1, S100A9, S100A8]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[NOD2, DLL1, TSPAN5, TGFB2, JAG1, ELF3, KIT, MAML3]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[IL10, JUN, IGFBP5, MMP2, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0046321;positive regulation of fatty acid oxidation;8.0;0.811012628672052;0.780506314336026;9.394909401310617;296.50567016851846;7.138016298065211;0.009923777942761737;0.7400384854347593;[FABP1, NR4A3, TWIST1]
GO:0071870;cellular response to catecholamine stimulus;7.0;0.8436909121759173;0.7727648213451592;9.454170865347344;343.956301250774;6.221725566191056;0.011511907862289356;0.6690987000520388;[IL1RN, HDAC2, LRRK2, PDE4D, DNM2, NR4A3, KCNQ1, ID1, PDE4B, SNCA]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PLEK, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, PARVB, KIT, S100A9]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[HOXA9, GPR171, HOXA7, HOXA5, KLF13, NME1, CEACAM1, RARA, TRIB1, TLR4, LTF, DLL1, INPP5D, LYN, LILRB1, INHBA, LILRB3, MEIS2, LILRB4, NFKBIA, MEIS1, MAFB, CDK6, PF4, FBN1, C1QC]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:0033153;T cell receptor V(D)J recombination;11.0;1.0;0.9324289523296623;9.628524252492122;333.8668407979641;8.16763571524637;0.011174222700858697;0.8501222226412654;[BCL11B, LEF1, TCF7]
GO:0060853;Notch signaling pathway involved in arterial endothelial cell fate commitment;7.0;1.0;0.8509193652572005;9.628524252492122;28.581916314885376;9.777073627680469;9.566110170045473E-4;0.8509193652572005;[DLL1]
GO:2000108;positive regulation of leukocyte apoptotic process;8.0;0.7192862368539868;0.7346431184269935;8.935377071932177;105.0692829116069;6.444869117505266;0.003516574342835972;0.7045909063862833;[LYN, IL10, CD274, MEF2C, ANXA1, PIK3CD, SIRT1, NR4A3, CCL5, ADAM8, NFKBID]
GO:0014807;regulation of somitogenesis;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;45.909253739235254;7.57984905034425;0.0015365414070062774;0.710754145523778;[CDX2, CDX1, DLL1]
GO:0048752;semicircular canal morphogenesis;4.0;1.0;0.75;9.628524252492122;28.499391571831023;8.16763571524637;9.53848988121965E-4;0.6676932703116032;[NR4A3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, RPS6KB1, TEK, NAA15]
